CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Medicines against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of OsteoporosisCL BIOSCIENCESNov 17, 2021
Further Novel Forms Of Interfering Rna MoleculesATUGENOct 16, 2018
Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICSDec 14, 2017

Explore Medicines's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 10, 2022Intrautinary Systems, Iud Insertion Devices, And Related Methods And Kits Therefor1

Top competitors of Medicines

List of top competitors of Medicines based on patent oppositions.